Therapeutic role of growth factors in treating diabetic wound

Wounds in diabetic patients, especially diabetic foot ulcers, are more difficult to heal compared with normal wounds and can easily deteriorate, leading to amputation. Common treatments cannot heal diabetic wounds or control their many complications. Growth factors are found to play important roles in regulating complex diabetic wound healing. Different growth factors such as transforming growth factor beta 1, insulin-like growth factor, and vascular endothelial growth factor play different roles in diabetic wound healing. This implies that a therapeutic modality modulating different growth factors to suit wound healing can significantly improve the treatment of diabetic wounds. Further, some current treatments have been shown to promote the healing of diabetic wounds by modulating specific growth factors. The purpose of this study was to discuss the role played by each growth factor in therapeutic approaches so as to stimulate further therapeutic thinking.

[1]  Xinsong Li,et al.  Efficient delivery of VEGF-A mRNA for promoting diabetic wound healing via ionizable lipid nanoparticles. , 2022, International journal of pharmaceutics.

[2]  D. Janczak,et al.  Two-Stage Gene Therapy (VEGF, HGF and ANG1 Plasmids) as Adjunctive Therapy in the Treatment of Critical Lower Limb Ischemia in Diabetic Foot Syndrome , 2022, International journal of environmental research and public health.

[3]  Endeshaw Chekol Abebe,et al.  Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications , 2022, Frontiers in Molecular Biosciences.

[4]  Zongzhe Jiang,et al.  WDR74 facilitates TGF-β/Smad pathway activation to promote M2 macrophage polarization and diabetic foot ulcer wound healing in mice , 2022, Cell Biology and Toxicology.

[5]  E. Aborajooh,et al.  Diabetic foot ulcer in Southern Jordan: A cross-sectional Study of Clinical and Microbiological Aspects , 2022, Annals of medicine and surgery.

[6]  Ziqi Zheng,et al.  In-situ formable dextran/chitosan-based hydrogels functionalized with collagen and EGF for diabetic wounds healing. , 2022, Biomaterials advances.

[7]  OUP accepted manuscript , 2022, Burns and Trauma.

[8]  B. Duncan,et al.  IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 , 2021, Diabetes Research and Clinical Practice.

[9]  J. Hubbell,et al.  VEGF-A, PDGF-BB and HB-EGF engineered for promiscuous super affinity to the extracellular matrix improve wound healing in a model of type 1 diabetes , 2021, npj Regenerative Medicine.

[10]  R. Kirsner,et al.  Diabetic Wound-Healing Science , 2021, Medicina.

[11]  K. Toyka,et al.  Inflammatory Mechanisms in the Pathophysiology of Diabetic Peripheral Neuropathy (DN)—New Aspects , 2021, International journal of molecular sciences.

[12]  Ioannis D. Karantas,et al.  An Updated Review for the Diabetic Wound Healing Systems. , 2021, Current drug targets.

[13]  S. Bardosono,et al.  The role of VEGF, PDGF and IL-6 on diabetic foot ulcer after Platelet Rich Fibrin + hyaluronic therapy , 2021, Heliyon.

[14]  Haiping Wang,et al.  Baicalin regulates mRNA expression of VEGF‐c, Ang‐1/Tie2, TGF‐β and Smad2/3 to inhibit wound healing in streptozotocin‐induced diabetic foot ulcer rats , 2021, Journal of biochemical and molecular toxicology.

[15]  M. Abdelgawad,et al.  Prevalence of Peripheral Arterial Disease in Diabetic Foot Ulcer Patients and its Impact in Limb Salvage , 2021, The international journal of lower extremity wounds.

[16]  A. Marcinek,et al.  Differentiation of Diabetic Foot Ulcers Based on Stimulation of Myogenic Oscillations by Transient Ischemia , 2021, Vascular health and risk management.

[17]  Timothy J. Peters,et al.  A multiomics approach to identify host-microbe alterations associated with infection severity in diabetic foot infections: a pilot study , 2021, NPJ biofilms and microbiomes.

[18]  C. Assi,et al.  Is there an association between anemia and diabetic foot ulcers? A systematic review and meta‐analysis , 2021, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[19]  D. Armstrong,et al.  The Role of Oxidative Stress and Antioxidants in Diabetic Wound Healing , 2021, Oxidative medicine and cellular longevity.

[20]  J. V. van Baal,et al.  Clinical profiles of diabetic foot ulcer patients undergoing major limb amputation at a tertiary care center in North-eastern Tanzania , 2021, BMC Surgery.

[21]  T. Behl,et al.  Stem cells and growth factors-based delivery approaches for chronic wound repair and regeneration: A promise to heal from within. , 2021, Life sciences.

[22]  N. Lane,et al.  The evolution of nerve growth factor inhibition in clinical medicine , 2020, Nature Reviews Rheumatology.

[23]  L. Wise,et al.  Advancements in the delivery of growth factors and cytokines for the treatment of cutaneous wound indications. , 2020, Advances in wound care.

[24]  C. Cho,et al.  An EGF- and Curcumin-Co-Encapsulated Nanostructured Lipid Carrier Accelerates Chronic-Wound Healing in Diabetic Rats , 2020, Molecules.

[25]  E. Candi,et al.  Macrophage Activation and M2 Polarization in Wound Bed of Diabetic Patients Treated by Dermal/Epidermal Substitute Nevelia , 2020, The international journal of lower extremity wounds.

[26]  Lang Chen,et al.  Adipose-derived stem cells promote diabetic wound healing via the recruitment and differentiation of endothelial progenitor cells into endothelial cells mediated by the VEGF-PLCγ-ERK pathway. , 2020, Archives of biochemistry and biophysics.

[27]  Guohua Jiang,et al.  Rapid gelation of oxidized hyaluronic acid and succinyl chitosan for integration with insulin-loaded micelles and epidermal growth factor on diabetic wound healing. , 2020, Materials science & engineering. C, Materials for biological applications.

[28]  I. Gezawa,et al.  Determinants of wound healing in patients hospitalized for diabetic foot ulcer: results from the MEDFUN study , 2020, Endocrine regulations.

[29]  M. Hayden Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019 , 2020, The Journal of international medical research.

[30]  D. Armstrong,et al.  Comparison of Allogeneic Platelet-rich Plasma With Autologous Platelet-rich Plasma for the Treatment of Diabetic Lower Extremity Ulcers , 2020, Cell transplantation.

[31]  Yin‐peng Jin,et al.  Role and effect of vein-transplanted human umbilical cord mesenchymal stem cells in the repair of diabetic foot ulcers in rats , 2020, Acta biochimica et biophysica Sinica.

[32]  K. Ramkumar,et al.  Role of Nrf2 in MALAT1/ HIF-1α loop on the regulation of angiogenesis in diabetic foot ulcex. , 2020, Free radical biology & medicine.

[33]  D. Armstrong,et al.  An observational pilot study using a purified reconstituted bilayer matrix to treat non‐healing diabetic foot ulcers , 2020, International wound journal.

[34]  Aeri Kim,et al.  Improved Diabetic Wound Healing by EGF Encapsulation in Gelatin-Alginate Coacervates , 2020, Pharmaceutics.

[35]  D. Robertson,et al.  The IGF/Insulin-IGFBP Axis in Corneal Development, Wound Healing, and Disease , 2020, Frontiers in Endocrinology.

[36]  J. L. Gomez Ribelles,et al.  A new waterborne chitosan-based polyurethane hydrogel as a vehicle to transplant bone marrow mesenchymal cells improved wound healing of ulcers in a diabetic rat model. , 2020, Carbohydrate polymers.

[37]  S. Shirian,et al.  CD93 hematopoietic stem cells improve diabetic wound healing by VEGF activation and downregulation of DAPK‐1 , 2020, Journal of cellular physiology.

[38]  V. Viswanathan,et al.  Efficacy of Recombinant Human Epidermal Growth Factor (Regen-D 150) in Healing Diabetic Foot Ulcers: A Hospital-Based Randomized Controlled Trial , 2019, The international journal of lower extremity wounds.

[39]  Tianlun Yang,et al.  Improved therapeutic effects on diabetic foot by human mesenchymal stem cells expressing MALAT1 as a sponge for microRNA-205-5p , 2019, Aging.

[40]  I. Gezawa,et al.  Anemia in patients with diabetic foot ulcer and its impact on disease outcome among Nigerians: Results from the MEDFUN study , 2019, PloS one.

[41]  R. Kow,et al.  Predictive Factors of Major Lower Extremity Amputations in Diabetic Foot Infections: A Cross-sectional Study at District Hospital in Malaysia , 2019, Malaysian orthopaedic journal.

[42]  M. Dell’Agli,et al.  Effect of Hypoxia on Gene Expression in Cell Populations Involved in Wound Healing , 2019, BioMed research international.

[43]  M. Ahmedani,et al.  Strong association of anemia in people with diabetic foot ulcers (DFUs): Study from a specialist foot care center , 2019, Pakistan journal of medical sciences.

[44]  Bumjo Oh,et al.  Influence of Microbiota on Diabetic Foot Wound in Comparison with Adjacent Normal Skin Based on the Clinical Features , 2019, BioMed research international.

[45]  A. Pandit,et al.  Hyperglycemia acts in synergy with hypoxia to maintain the pro-inflammatory phenotype of macrophages , 2019, PloS one.

[46]  Daidi Fan,et al.  Dramatic promotion of wound healing using a recombinant human-like collagen and bFGF cross-linked hydrogel by transglutaminase , 2019, Journal of biomaterials science. Polymer edition.

[47]  Yoshiro Kato,et al.  Diabetic neuropathy , 2019, Nature Reviews Disease Primers.

[48]  J. Ahmad,et al.  Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review , 2019, Reviews in Endocrine and Metabolic Disorders.

[49]  S. Tewari,et al.  The Role of Oxidative Stress in the Development of Diabetes Mellitus and Its Complications , 2019, Journal of diabetes research.

[50]  Satish Patel,et al.  Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[51]  M. Minaiyan,et al.  Nanocrystalline cellulose–hyaluronic acid composite enriched with GM-CSF loaded chitosan nanoparticles for enhanced wound healing , 2019, Biomedical materials.

[52]  Yong Wang,et al.  Assembly of Bifunctional Aptamer-Fibrinogen Macromer for VEGF Delivery and Skin Wound Healing. , 2019, Chemistry of materials : a publication of the American Chemical Society.

[53]  S. Atkin,et al.  A review of the molecular mechanisms of hyperglycemia‐induced free radical generation leading to oxidative stress , 2018, Journal of cellular physiology.

[54]  Rui Carvalho,et al.  Topic platelet gel application in chronic diabetic foot ulcers. , 2019, Diabetes & metabolic syndrome.

[55]  M. Dubský,et al.  Endothelial Progenitor Cells Biology in Diabetes Mellitus and Peripheral Arterial Disease and their Therapeutic Potential , 2018, Stem Cell Reviews and Reports.

[56]  K. Hansson,et al.  Modified VEGF-A mRNA induces sustained multifaceted microvascular response and accelerates diabetic wound healing , 2018, Scientific Reports.

[57]  M. Soligo,et al.  Nerve Growth Factor: Early Studies and Recent Clinical Trials , 2018, Current neuropharmacology.

[58]  F. Coşkun,et al.  Efficacy of Hyperbaric Oxygen Therapy in Diabetic Foot Ulcers Based on Wagner Classification , 2018, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[59]  R. Adam,et al.  Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a Critical Mediator of Tissue Repair and Regeneration. , 2018, The American journal of pathology.

[60]  X. Luan,et al.  Dysfunction and Therapeutic Potential of Endothelial Progenitor Cells in Diabetes Mellitus , 2018, Journal of clinical medicine research.

[61]  I. Widiana,et al.  A Pilot Study of Short-Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patients with Diabetic Foot Ulcer Wagner 3-4 , 2018, TheScientificWorldJournal.

[62]  Jatin Kalita,et al.  Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets , 2018, European journal of pharmacology.

[63]  S. Han,et al.  Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial. , 2018, Diabetes research and clinical practice.

[64]  D. Wågsäter,et al.  PDGF-C and PDGF-D signaling in vascular diseases and animal models. , 2018, Molecular aspects of medicine.

[65]  Kwang-Hyeon Liu,et al.  Impaired permeability and antimicrobial barriers in type 2 diabetes skin are linked to increased serum levels of advanced glycation end‐product , 2018, Experimental dermatology.

[66]  Yin‐peng Jin,et al.  Nanosphere-mediated co-delivery of VEGF-A and PDGF-B genes for accelerating diabetic foot ulcers healing in rats , 2018, Gene Therapy.

[67]  Dawei Li,et al.  Dual-Crosslinked Amorphous Polysaccharide Hydrogels Based on Chitosan/Alginate for Wound Healing Applications. , 2018, Macromolecular rapid communications.

[68]  Ji-Seon Lee,et al.  Enhancement of wound healing efficiency mediated by artificial dermis functionalized with EGF or NRG1 , 2018, Biomedical materials.

[69]  M. Vossoughi,et al.  Accelerated full-thickness wound healing via sustained bFGF delivery based on a PVA/chitosan/gelatin hydrogel incorporating PCL microspheres. , 2018, International journal of pharmaceutics.

[70]  Y. Terauchi,et al.  Aging-like physiological changes in the skin of Japanese obese diabetic patients , 2018, SAGE open medicine.

[71]  A. Eatemadi,et al.  Diabetic ulcer regeneration: stem cells, biomaterials, growth factors , 2018, Artificial cells, nanomedicine, and biotechnology.

[72]  F. O'Brien,et al.  Innovations in gene and growth factor delivery systems for diabetic wound healing , 2017, Journal of tissue engineering and regenerative medicine.

[73]  Song‐Pyo Hong,et al.  Surgical Denervation of Specific Cutaneous Nerves Impedes Excisional Wound Healing of Small Animal Ear Pinnae , 2018, Molecular Neurobiology.

[74]  P. Prakash,et al.  Culture characterization of the skin microbiome in Type 2 diabetes mellitus: A focus on the role of innate immunity. , 2017, Diabetes research and clinical practice.

[75]  Yitao Wang,et al.  In situ sequestration of endogenous PDGF-BB with an ECM-mimetic sponge for accelerated wound healing. , 2017, Biomaterials.

[76]  M. Roden,et al.  Patterns of cutaneous nerve fibre loss and regeneration in type 2 diabetes with painful and painless polyneuropathy , 2017, Diabetologia.

[77]  G. Caetano,et al.  Skin changes in streptozotocin-induced diabetic rats. , 2017, Biochemical and biophysical research communications.

[78]  F. Acosta,et al.  Nanodiamond-based injectable hydrogel for sustained growth factor release: Preparation, characterization and in vitro analysis. , 2017, Acta biomaterialia.

[79]  A. Darling,et al.  A longitudinal study of the diabetic skin and wound microbiome , 2017, PeerJ.

[80]  M. Rafiee-Tehrani,et al.  G-CSF loaded nanofiber/nanoparticle composite coated with collagen promotes wound healing in vivo. , 2017, Journal of biomedical materials research. Part A.

[81]  J. Hubbell,et al.  Local induction of lymphangiogenesis with engineered fibrin-binding VEGF-C promotes wound healing by increasing immune cell trafficking and matrix remodeling. , 2017, Biomaterials.

[82]  L. DiPietro,et al.  Diabetes and Wound Angiogenesis , 2017, International journal of molecular sciences.

[83]  Wei Xue,et al.  Acceleration of skin regeneration in full‐thickness burns by incorporation of bFGF‐loaded alginate microspheres into a CMCS–PVA hydrogel , 2017, Journal of tissue engineering and regenerative medicine.

[84]  Arya M. Sharma,et al.  Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy , 2017, BMJ Open Diabetes Research & Care.

[85]  A. Dardik,et al.  Diabetic foot ulcer carries high amputation and mortality rates, particularly in the presence of advanced age, peripheral artery disease and anemia. , 2017, Diabetes & metabolic syndrome.

[86]  P. Elsner,et al.  Cutaneous Manifestations of Diabetes Mellitus: A Review , 2017, American Journal of Clinical Dermatology.

[87]  H. Abboud,et al.  Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells , 2017, Journal of Biological Chemistry.

[88]  Shaoling Yang,et al.  Pathophysiology of peripheral arterial disease in diabetes mellitus , 2017, Journal of diabetes.

[89]  Zhiguo Zheng,et al.  Curcumol Promotes Vascular Endothelial Growth Factor (VEGF)-Mediated Diabetic Wound Healing in Streptozotocin-Induced Hyperglycemic Rats , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[90]  Wael A Alanazi,et al.  Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury , 2017, Journal of diabetes research.

[91]  G. Fu,et al.  PKC/NADPH oxidase are involved in the protective effect of pioglitazone in high homocysteine-induced paracrine dyfunction in endothelial progenitor cells. , 2017, American journal of translational research.

[92]  M. Báez,et al.  Handcrafted Vacuum-Assisted Device for Skin Ulcers Treatment Versus Traditional Therapy, Randomized Controlled Trial , 2017, World Journal of Surgery.

[93]  Robert S. Kirsner,et al.  Integrative analysis of miRNA and mRNA paired expression profiling of primary fibroblast derived from diabetic foot ulcers reveals multiple impaired cellular functions , 2016, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[94]  F. O'Brien,et al.  Delivering Nucleic‐Acid Based Nanomedicines on Biomaterial Scaffolds for Orthopedic Tissue Repair: Challenges, Progress and Future Perspectives , 2016, Advanced materials.

[95]  D. Mooney,et al.  Altered ECM deposition by diabetic foot ulcer‐derived fibroblasts implicates fibronectin in chronic wound repair , 2016, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[96]  A. Isidori,et al.  Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes , 2016, Journal of Endocrinological Investigation.

[97]  A. Bayat,et al.  The Role of Neuromediators and Innervation in Cutaneous Wound Healing. , 2016, Acta dermato-venereologica.

[98]  Ralf Lobmann,et al.  Neuropathy and Diabetic Foot Syndrome , 2016, International journal of molecular sciences.

[99]  B. Larijani,et al.  Preparation of hydrogel embedded polymer-growth factor conjugated nanoparticles as a diabetic wound dressing , 2016, Drug development and industrial pharmacy.

[100]  A. MacLeod,et al.  The Innate Immune System in Acute and Chronic Wounds , 2016, Advances in wound care.

[101]  Y. Tabata,et al.  Proapoptotic effect of control‐released basic fibroblast growth factor on skin wound healing in a diabetic mouse model , 2016, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[102]  M. Maitz,et al.  Heparin desulfation modulates VEGF release and angiogenesis in diabetic wounds. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[103]  D. Pyun,et al.  Polyurethane foam containing rhEGF as a dressing material for healing diabetic wounds: Synthesis, characterization, in vitro and in vivo studies. , 2015, Colloids and surfaces. B, Biointerfaces.

[104]  P. Carmeliet,et al.  Combined effects of PLGA and vascular endothelial growth factor promote the healing of non-diabetic and diabetic wounds. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[105]  Shih-Jung Liu,et al.  Promoting Diabetic Wound Therapy Using Biodegradable rhPDGF-Loaded Nanofibrous Membranes , 2015, Medicine.

[106]  A. Ahluwalia,et al.  Nerve growth factor injected into the gastric ulcer base incorporates into endothelial, neuronal, glial and epithelial cells: implications for angiogenesis, mucosal regeneration and ulcer healing. , 2015, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[107]  P. Hammond,et al.  Combination Growth Factor Therapy via Electrostatically Assembled Wound Dressings Improves Diabetic Ulcer Healing In Vivo , 2015, Advanced healthcare materials.

[108]  N. Johnson,et al.  Coacervate delivery of HB‐EGF accelerates healing of type 2 diabetic wounds , 2015, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[109]  T. Segura,et al.  Porous Hyaluronic Acid Hydrogels for Localized Nonviral DNA Delivery in a Diabetic Wound Healing Model , 2015, Advanced healthcare materials.

[110]  R. Forsythe,et al.  Peripheral arterial disease and revascularization of the diabetic foot , 2015, Diabetes, obesity & metabolism.

[111]  Li-Jung Liang,et al.  Topical platelet-derived growth factor vs placebo therapy of diabetic foot ulcers offloaded with windowed casts: a randomized, controlled trial. , 2015, Wounds : a compendium of clinical research and practice.

[112]  D. Mooney,et al.  Three-dimensional human tissue models that incorporate diabetic foot ulcer-derived fibroblasts mimic in vivo features of chronic wounds. , 2015, Tissue engineering. Part C, Methods.

[113]  P. Boughton,et al.  Topically Applied Connective Tissue Growth Factor/CCN2 Improves Diabetic Preclinical Cutaneous Wound Healing: Potential Role for CTGF in Human Diabetic Foot Ulcer Healing , 2015, Journal of diabetes research.

[114]  Jingqiu Cheng,et al.  Metabonomics revealed xanthine oxidase-induced oxidative stress and inflammation in the pathogenesis of diabetic nephropathy , 2015, Analytical and Bioanalytical Chemistry.

[115]  L. Philipson,et al.  Update on diabetes classification. , 2015, The Medical clinics of North America.

[116]  J. Hoeijmakers,et al.  An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. , 2014, Developmental cell.

[117]  Paul Martin,et al.  Wound repair and regeneration: Mechanisms, signaling, and translation , 2014, Science Translational Medicine.

[118]  T. Zhou,et al.  High Levels of Pigment Epithelium–Derived Factor in Diabetes Impair Wound Healing Through Suppression of Wnt Signaling , 2014, Diabetes.

[119]  Suhong Xu,et al.  C. elegans epidermal wounding induces a mitochondrial ROS burst that promotes wound repair. , 2014, Developmental cell.

[120]  Hsi-Chin Wu,et al.  Tailored design of electrospun composite nanofibers with staged release of multiple angiogenic growth factors for chronic wound healing. , 2014, Acta biomaterialia.

[121]  T. Wilgus,et al.  Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair. , 2014, Advances in wound care.

[122]  Y. Xuan,et al.  High-Glucose Inhibits Human Fibroblast Cell Migration in Wound Healing via Repression of bFGF-Regulating JNK Phosphorylation , 2014, PloS one.

[123]  O. Stojadinović,et al.  Clinical application of growth factors and cytokines in wound healing , 2014, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[124]  J. Pedraz,et al.  A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: In vitro bioactivity and in vivo effectiveness in healing-impaired db/db mice. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[125]  J. Contreras-Ruiz,et al.  Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: A randomized double‐blinded controlled trial , 2014, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[126]  Jung-whan Kim,et al.  Regulation of Wound Healing and Fibrosis by Hypoxia and Hypoxia-Inducible Factor-1 , 2014, Molecules and cells.

[127]  M. Roden,et al.  Early Detection of Nerve Fiber Loss by Corneal Confocal Microscopy and Skin Biopsy in Recently Diagnosed Type 2 Diabetes , 2014, Diabetes.

[128]  Stephen A. Goutman,et al.  Painful diabetic neuropathy , 2014, BMJ : British Medical Journal.

[129]  N. Ferrara,et al.  Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice. , 2014, Journal of vascular surgery.

[130]  Ashutosh Kumar,et al.  Neuroinflammation and Oxidative Stress in Diabetic Neuropathy: Futuristic Strategies Based on These Targets , 2014, International journal of endocrinology.

[131]  Mikaël M. Martino,et al.  Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164 , 2014, Proceedings of the National Academy of Sciences.

[132]  P. A. Harding,et al.  Heparin-binding epidermal growth factor-like growth factor (HB-EGF) and proteolytic processing by a disintegrin and metalloproteinases (ADAM): a regulator of several pathways. , 2014, Seminars in cell & developmental biology.

[133]  D. Fulton,et al.  Regulation of NADPH Oxidase 5 by Protein Kinase C Isoforms , 2014, PloS one.

[134]  Shigehiko Suzuki,et al.  Evaluation of a novel collagen–gelatin scaffold for achieving the sustained release of basic fibroblast growth factor in a diabetic mouse model , 2014, Journal of tissue engineering and regenerative medicine.

[135]  H. C. de Sousa,et al.  Neurotensin-loaded collagen dressings reduce inflammation and improve wound healing in diabetic mice. , 2014, Biochimica et biophysica acta.

[136]  G. Gadomska,et al.  VEGF-A and PDGF-BB--angiogenic factors and the stage of diabetic foot syndrome advancement. , 2014, Endokrynologia Polska.

[137]  J. Pedraz,et al.  rhEGF-loaded PLGA-Alginate microspheres enhance the healing of full-thickness excisional wounds in diabetised Wistar rats. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[138]  K. Scharffetter-Kochanek,et al.  Disclosure of the Culprits: Macrophages-Versatile Regulators of Wound Healing. , 2013, Advances in wound care.

[139]  G. Lina,et al.  Distribution of edin in Staphylococcus aureus isolated from diabetic foot ulcers. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[140]  F. Chiellini,et al.  Fibrin-based scaffold incorporating VEGF- and bFGF-loaded nanoparticles stimulates wound healing in diabetic mice. , 2013, Acta biomaterialia.

[141]  D. Ziegler,et al.  Novel pathogenic pathways in diabetic neuropathy , 2013, Trends in Neurosciences.

[142]  H. C. de Sousa,et al.  Recent advances on the development of wound dressings for diabetic foot ulcer treatment--a review. , 2013, Acta biomaterialia.

[143]  L K Chin,et al.  Study of endothelial cell apoptosis using fluorescence resonance energy transfer (FRET) biosensor cell line with hemodynamic microfluidic chip system. , 2013, Lab on a chip.

[144]  M. Yokode,et al.  Novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor: clinical trial for chronic skin ulcers. , 2013, Tissue engineering. Part A.

[145]  G. Weinstock,et al.  Quantitation and composition of cutaneous microbiota in diabetic and nondiabetic men. , 2013, The Journal of infectious diseases.

[146]  P. Peplow,et al.  A review of the influence of growth factors and cytokines in in vitro human keratinocyte migration. , 2013, Cytokine.

[147]  D. G. Armstrong,et al.  Expression of cell proliferation cycle negative regulators in fibroblasts of an ischemic diabetic foot ulcer. A clinical case report , 2013, International wound journal.

[148]  M. Cremer,et al.  Novel Higher-Order Epigenetic Regulation of the Bdnf Gene upon Seizures , 2013, The Journal of Neuroscience.

[149]  Dhiren P. Shah,et al.  ON OXIDATIVE STRESS AND DIABETIC COMPLICATIONS , 2013 .

[150]  N. Dai,et al.  Adipose-Derived Stem Cells Seeded on Acellular Dermal Matrix Grafts Enhance Wound Healing in a Murine Model of a Full-Thickness Defect , 2012, Annals of plastic surgery.

[151]  Lorenzo Moroni,et al.  Cationic polymers and their therapeutic potential. , 2012, Chemical Society reviews.

[152]  Y. Kuroyanagi,et al.  Evaluation of a Wound Dressing Composed of Hyaluronic Acid and Collagen Sponge Containing Epidermal Growth Factor in Diabetic Mice , 2012, Journal of biomaterials science. Polymer edition.

[153]  Michael Landthaler,et al.  Cytokines, chemokines and growth factors in wound healing , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[154]  S. Basir,et al.  Strengthening of antioxidant defense by Azadirachta indica in alloxan-diabetic rat tissues , 2012, Journal of Ayurveda and integrative medicine.

[155]  B. Wolffenbuttel,et al.  Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers , 2012, Diabetologia.

[156]  G. Gutiérrez-Ospina,et al.  Modulatory Role of Sensory Innervation on Hair Follicle Stem Cell Progeny during Wound Healing of the Rat Skin , 2012, PloS one.

[157]  F. Bowling,et al.  Molecular and Culture-Based Assessment of the Microbial Diversity of Diabetic Chronic Foot Wounds and Contralateral Skin Sites , 2012, Journal of Clinical Microbiology.

[158]  Ji-Seon Lee,et al.  Genetic modification of human adipose-derived stem cells for promoting wound healing. , 2012, Journal of dermatological science.

[159]  H. Jung,et al.  Effective healing of diabetic skin wounds by using nonviral gene therapy based on minicircle vascular endothelial growth factor DNA and a cationic dendrimer , 2012, The journal of gene medicine.

[160]  C. Chao,et al.  Effect of Glycemic Control on Sudomotor Denervation in Type 2 Diabetes , 2012, Diabetes Care.

[161]  A. Metcalfe,et al.  Denervation affects regenerative responses in MRL/MpJ and repair in C57BL/6 ear wounds , 2012, Journal of anatomy.

[162]  Shuhui He,et al.  Electrospun fibers with plasmid bFGF polyplex loadings promote skin wound healing in diabetic rats. , 2012, Molecular pharmaceutics.

[163]  Irma E. Gonzalez-Curiel,et al.  Expression of antimicrobial peptides in diabetic foot ulcer. , 2012, Journal of dermatological science.

[164]  Hwa-Young Park,et al.  A long‐standing hyperglycaemic condition impairs skin barrier by accelerating skin ageing process , 2011, Experimental dermatology.

[165]  E. Raines,et al.  History of discovery: platelet-derived growth factor. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[166]  D. Sheppard,et al.  Cross talk among TGF-β signaling pathways, integrins, and the extracellular matrix. , 2011, Cold Spring Harbor perspectives in biology.

[167]  C. Chao,et al.  Quantitation of Sudomotor Innervation in Skin Biopsies of Patients With Diabetic Neuropathy , 2011, Journal of neuropathology and experimental neurology.

[168]  Chunmao Han,et al.  Topically applied rhGM-CSF for the wound healing: a systematic review. , 2011, Burns : journal of the International Society for Burn Injuries.

[169]  R. Duncan,et al.  The effect of dextrin-rhEGF on the healing of full-thickness, excisional wounds in the (db/db) diabetic mouse. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[170]  Wei Zhi,et al.  Promotion of skin regeneration in diabetic rats by electrospun core-sheath fibers loaded with basic fibroblast growth factor. , 2011, Biomaterials.

[171]  J. McArthur,et al.  Impaired neurovascular repair in subjects with diabetes following experimental intracutaneous axotomy. , 2011, Brain : a journal of neurology.

[172]  Zhifeng Xiao,et al.  Improved cellularization and angiogenesis using collagen scaffolds chemically conjugated with vascular endothelial growth factor. , 2011, Acta biomaterialia.

[173]  Cord Sunderkötter,et al.  An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. , 2011, The Journal of clinical investigation.

[174]  J. Pfeilschifter,et al.  Wound Healing in Mice with High-Fat Diet- or ob Gene-Induced Diabetes-Obesity Syndromes: A Comparative Study , 2011, Experimental diabetes research.

[175]  Zhifeng Xiao,et al.  Acceleration of diabetic wound healing by collagen-binding vascular endothelial growth factor in diabetic rat model. , 2010, Diabetes research and clinical practice.

[176]  A. Boulton What you can't feel can hurt you. , 2010, Journal of vascular surgery.

[177]  Jun Xu,et al.  Nanotechnology promotes the full‐thickness diabetic wound healing effect of recombinant human epidermal growth factor in diabetic rats , 2010, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[178]  T. Ochiya,et al.  Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice , 2010, Genetic vaccines and therapy.

[179]  Eunseog Youn,et al.  A Comparison of Bacterial Composition in Diabetic Ulcers and Contralateral Intact Skin , 2010, The open microbiology journal.

[180]  E. Collard,et al.  Macrophage Dysfunction Impairs Resolution of Inflammation in the Wounds of Diabetic Mice , 2010, PloS one.

[181]  L. DiPietro,et al.  Factors Affecting Wound Healing , 2010, Journal of dental research.

[182]  O. Stojadinović,et al.  Attenuation of the Transforming Growth Factor β-Signaling Pathway in Chronic Venous Ulcers , 2010, Molecular medicine.

[183]  B. de Crombrugghe,et al.  Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure. , 2010, The American journal of pathology.

[184]  Tomaz Velnar,et al.  The Wound Healing Process: An Overview of the Cellular and Molecular Mechanisms , 2009, The Journal of international medical research.

[185]  K. Urabe,et al.  Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. , 2009, European journal of dermatology : EJD.

[186]  O. Stojadinović,et al.  Mechanism of sustained release of vascular endothelial growth factor in accelerating experimental diabetic healing. , 2009, Journal of Investigative Dermatology.

[187]  M. Paulsson,et al.  Alternative proteolytic processing of hepatocyte growth factor during wound repair. , 2009, The American journal of pathology.

[188]  E. Jude,et al.  Altered Molecular Mechanisms of Diabetic Foot Ulcers , 2009, The international journal of lower extremity wounds.

[189]  Jayanta Bhattacharyya,et al.  Single subcutaneous administration of RGDK-lipopeptide:rhPDGF-B gene complex heals wounds in streptozotocin-induced diabetic rats. , 2009, Molecular pharmaceutics.

[190]  N. Renda,et al.  Epidermal growth factor‐containing wound closure enhances wound healing in non‐diabetic and diabetic rats , 2009, International wound journal.

[191]  W. Marston,et al.  Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. , 2009, Journal of vascular surgery.

[192]  L. Tang,et al.  Functional bilayered skin substitute constructed by tissue-engineered extracellular matrix and microsphere-incorporated gelatin hydrogel for wound repair. , 2009, Tissue engineering. Part A.

[193]  Thomas E. Lyons,et al.  Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. , 2009, The Journal of clinical endocrinology and metabolism.

[194]  R. Goldschmeding,et al.  Connective tissue growth factor and cardiac fibrosis , 2009, Acta physiologica.

[195]  A. Grobbelaar,et al.  Transforming growth factor β1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance , 2009, Postgraduate Medical Journal.

[196]  S. H. Lee,et al.  Sonoporation of the Minicircle-VEGF165 for Wound Healing of Diabetic Mice , 2009, Pharmaceutical Research.

[197]  Weicai Wang,et al.  Repair effect of diabetic ulcers with recombinant human epidermal growth factor loaded by sustained-release microspheres , 2008, Science in China Series C: Life Sciences.

[198]  Huafeng Zhang,et al.  Age‐dependent impairment of HIF‐1α expression in diabetic mice: Correction with electroporation‐facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells , 2008, Journal of cellular physiology.

[199]  S. H. Kim,et al.  The Effect of Continuous Release of Recombinant Human Epidermal Growth Factor (rh-EGF) in Chitosan Film on Full Thickness Excisional Porcine Wounds , 2008, Annals of plastic surgery.

[200]  D. Woodley,et al.  The Role of Oxygen in Wound Healing: A Review of the Literature , 2008, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[201]  Y. Kurihara,et al.  Roles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[202]  J. Davidson First-class delivery: getting growth factors to their destination. , 2008, The Journal of investigative dermatology.

[203]  Vandana Iyer,et al.  Integrin α3β1 potentiates TGFβ-mediated induction of MMP-9 in immortalized keratinocytes , 2008 .

[204]  Chih-Hui Yang Evaluation of the release rate of bioactive recombinant human epidermal growth factor from crosslinking collagen sponges , 2008, Journal of materials science. Materials in medicine.

[205]  Xiaobing Fu,et al.  Research of PDGF-BB gel on the wound healing of diabetic rats and its pharmacodynamics. , 2008, The Journal of surgical research.

[206]  Kam W Leong,et al.  In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). , 2008, Biomaterials.

[207]  Gerry Rayman,et al.  Neurovascular Factors in Wound Healing in the Foot Skin of Type 2 Diabetic Subjects , 2008, Diabetes Care.

[208]  Xiaokun Li,et al.  Acceleration of diabetic wound healing with chitosan-crosslinked collagen sponge containing recombinant human acidic fibroblast growth factor in healing-impaired STZ diabetic rats. , 2008, Life sciences.

[209]  J. Hanft,et al.  Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers. , 2008, Journal of wound care.

[210]  G. Marti,et al.  KGF-1 for wound healing in animal models. , 2008, Methods in molecular biology.

[211]  Vandana Iyer,et al.  Integrin alpha3beta1 potentiates TGFbeta-mediated induction of MMP-9 in immortalized keratinocytes. , 2008, The Journal of investigative dermatology.

[212]  P. Sipkema,et al.  Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity , 2008, Cell and Tissue Research.

[213]  B. Cronstein,et al.  Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. , 2007, The American journal of pathology.

[214]  W. Jiang,et al.  Hepatocyte growth factor regulation: An integral part of why wounds become chronic , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[215]  Po-Len Liu,et al.  High Glucose Impairs Early and Late Endothelial Progenitor Cells by Modifying Nitric Oxide–Related but Not Oxidative Stress–Mediated Mechanisms , 2007, Diabetes.

[216]  R. Isseroff,et al.  Wound re-epithelialization: modulating keratinocyte migration in wound healing. , 2007, Frontiers in bioscience : a journal and virtual library.

[217]  Marjana Tomic-Canic,et al.  Cellular and molecular basis of wound healing in diabetes. , 2007, The Journal of clinical investigation.

[218]  S. Werner,et al.  c-Met is essential for wound healing in the skin , 2007, The Journal of cell biology.

[219]  E. Maltezos,et al.  Growth Factors in the Treatment of Diabetic Foot Ulcers: New Technologies, Any Promises? , 2007, The international journal of lower extremity wounds.

[220]  P. Connell,et al.  High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF-1alpha-dependent pathway. , 2007, Journal of molecular and cellular cardiology.

[221]  Glenn D Prestwich,et al.  Release of basic fibroblast growth factor from a crosslinked glycosaminoglycan hydrogel promotes wound healing , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[222]  Z. Sheng,et al.  Recombinant human platelet-derived growth factor enhanced dermal wound healing by a pathway involving ERK and c-fos in diabetic rats. , 2007, Journal of dermatological science.

[223]  A. Gabrielli,et al.  Collagen loss and impaired wound healing is associated with c‐Myb deficiency , 2007, The Journal of pathology.

[224]  Zhifeng Xiao,et al.  Collagen membranes loaded with collagen-binding human PDGF-BB accelerate wound healing in a rabbit dermal ischemic ulcer model , 2007, Growth factors.

[225]  Olivera Stojadinovic,et al.  Molecular Markers in Patients with Chronic Wounds to Guide Surgical Debridement , 2007, Molecular medicine.

[226]  Shingo Nakamura,et al.  Therapeutic angiogenesis induced by controlled release of fibroblast growth factor‐2 from injectable chitosan/non‐anticoagulant heparin hydrogel in a rat hindlimb ischemia model , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[227]  H. Schluesener,et al.  Mammalian toll-like receptors: from endogenous ligands to tissue regeneration , 2006, Cellular and Molecular Life Sciences CMLS.

[228]  Y. Tabata,et al.  Collagen–poly glycolic acid hybrid matrix with basic fibroblast growth factor accelerated angiogenesis and granulation tissue formation in diabetic mice , 2006, The Journal of dermatology.

[229]  Seppo Yla-Herttuala,et al.  Vascular endothelial growth factor-C accelerates diabetic wound healing. , 2006, The American journal of pathology.

[230]  A. Dellon,et al.  Wound Healing in Denervated Tissue , 2006, Annals of plastic surgery.

[231]  Wei Li,et al.  Transforming growth factor-alpha: a major human serum factor that promotes human keratinocyte migration. , 2006, The Journal of investigative dermatology.

[232]  Shubiao Zhang,et al.  Toxicity of cationic lipids and cationic polymers in gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[233]  Ann Marie Schmidt,et al.  Advanced glycation end products: sparking the development of diabetic vascular injury. , 2006, Circulation.

[234]  W. Karnafel,et al.  Neurogenic factors in the impaired healing of diabetic foot ulcers. , 2006, The Journal of surgical research.

[235]  O. Ishikawa,et al.  Basic fibroblast growth factor stimulates human keratinocyte motility by Rac activation , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[236]  D. Steed Clinical Evaluation of Recombinant Human Platelet-Derived Growth Factor for the Treatment of Lower Extremity Ulcers , 2006, Plastic and reconstructive surgery.

[237]  M. Gnant,et al.  VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. , 2006, Surgery.

[238]  Fatih Zor,et al.  An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factor. , 2006, Burns : journal of the International Society for Burn Injuries.

[239]  Y. Kim,et al.  Recombinant Human Epidermal Growth Factor (EGF) to Enhance Healing for Diabetic Foot Ulcers , 2006, Annals of plastic surgery.

[240]  Rodney K. Chan,et al.  Effect of Recombinant Platelet-Derived Growth Factor (Regranex®) on Wound Closure in Genetically Diabetic Mice , 2006, Journal of burn care & research : official publication of the American Burn Association.

[241]  S. Bale,et al.  Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris , 2006, Nature Genetics.

[242]  W. Jiang,et al.  The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing. , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[243]  K. Pietras,et al.  Platelet-Derived Growth Factor D Induces Cardiac Fibrosis and Proliferation of Vascular Smooth Muscle Cells in Heart-Specific Transgenic Mice , 2005, Circulation research.

[244]  Glenn D Prestwich,et al.  Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. , 2005, Biomaterials.

[245]  J. Mason,et al.  Lentiviral Transfection with the PDGF-B Gene Improves Diabetic Wound Healing , 2005, Plastic and reconstructive surgery.

[246]  T. Kawai,et al.  Acceleration of wound healing in healing‐impaired db/db mice with a photocrosslinkable chitosan hydrogel containing fibroblast growth factor‐2 , 2005, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[247]  T. Dinh,et al.  Microcirculation of the diabetic foot. , 2005, Current pharmaceutical design.

[248]  E. Mekada,et al.  Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing , 2005, Journal of Cell Science.

[249]  H. Kitano,et al.  A comprehensive pathway map of epidermal growth factor receptor signaling , 2005, Molecular systems biology.

[250]  A. Roberts,et al.  Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-α and TGF-β , 2005, Journal of Cell Science.

[251]  G. Schuler,et al.  Hyperglycemia Reduces Survival and Impairs Function of Circulating Blood-Derived Progenitor Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[252]  M. Santoro,et al.  Cellular and molecular facets of keratinocyte reepithelization during wound healing. , 2005, Experimental cell research.

[253]  K. Hörmann,et al.  TGF-beta antisense oligonucleotides reduce mRNA expression of matrix metalloproteinases in cultured wound-healing-related cells. , 2005, International journal of molecular medicine.

[254]  S. Hsieh,et al.  Skin denervation, neuropathology, and neuropathic pain in a laser-induced focal neuropathy , 2005, Neurobiology of Disease.

[255]  Y. Ikada,et al.  Effects of bFGF incorporated into a gelatin sheet on wound healing , 2005, Journal of biomaterials science. Polymer edition.

[256]  Y. Gho,et al.  Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway. , 2005, Circulation research.

[257]  A. Roberts,et al.  Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta. , 2005, Journal of cell science.

[258]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[259]  G. Marti,et al.  Electroporative transfection with KGF-1 DNA improves wound healing in a diabetic mouse model , 2004, Gene Therapy.

[260]  L. Poellinger,et al.  Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. , 2004, Diabetes.

[261]  K. Alitalo,et al.  PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. , 2004, Blood.

[262]  M. Matucci Cerinic,et al.  Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases. , 2004, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[263]  M. Herlyn,et al.  Adenoviral mediated gene transfer of PDGF‐B enhances wound healing in type I and type II diabetic wounds , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[264]  Leaf Huang,et al.  Electroporatic delivery of TGF-beta1 gene works synergistically with electric therapy to enhance diabetic wound healing in db/db mice. , 2004, The Journal of investigative dermatology.

[265]  C. Doillon,et al.  Denatured collagen as support for a FGF-2 delivery system: physicochemical characterizations and in vitro release kinetics and bioactivity. , 2004, Biomaterials.

[266]  M. Loeken,et al.  Activation of the hexosamine pathway causes oxidative stress and abnormal embryo gene expression: involvement in diabetic teratogenesis. , 2004, Birth defects research. Part A, Clinical and molecular teratology.

[267]  S. Gilbey Neuropathy and foot problems in diabetes. , 2004, Clinical medicine.

[268]  Whei-Min Lin,et al.  Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. , 2004, Brain : a journal of neurology.

[269]  S. Werner,et al.  Fibroblast growth factors in epithelial repair and cytoprotection. , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[270]  N. Vaziri,et al.  Dysregulation of Hepatic Superoxide Dismutase, Catalase and Glutathione Peroxidase in Diabetes: Response to Insulin and Antioxidant Therapies , 2004, Clinical and experimental hypertension.

[271]  Leaf Huang,et al.  Thermosensitive Hydrogel as a Tgf-β1 Gene Delivery Vehicle Enhances Diabetic Wound Healing , 2003, Pharmaceutical Research.

[272]  Leaf Huang,et al.  Intradermal Injection of Transforming Growth Factor-β1 Gene Enhances Wound Healing in Genetically Diabetic Mice , 2003, Pharmaceutical Research.

[273]  J. Polak,et al.  Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: an immunocytochemical study , 1989, Diabetologia.

[274]  R. Kirsner,et al.  Clinical practice. Neuropathic diabetic foot ulcers. , 2004, The New England journal of medicine.

[275]  Frank J T Staal,et al.  Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. , 2004, Diabetes.

[276]  F. Bonte,et al.  Expression and function of neurotrophins and their receptors in cultured human keratinocytes. , 2003, The Journal of investigative dermatology.

[277]  M. Cesari,et al.  Topical Treatment of Pressure Ulcers with Nerve Growth Factor , 2003, Annals of Internal Medicine.

[278]  R. Moritz,et al.  Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D , 2003, The Journal of experimental medicine.

[279]  Masanori Fujita,et al.  Photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 stimulates wound healing in healing-impaired db/db mice. , 2003, Biomaterials.

[280]  T. Cheng,et al.  Effects of the nerve growth factor on the survival and wound healing in mice with combined radiation and wound injury. , 2003, Journal of radiation research.

[281]  Sookja K. Chung,et al.  Contribution of polyol pathway to diabetes-induced oxidative stress. , 2003, Journal of the American Society of Nephrology : JASN.

[282]  S. Werner,et al.  Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.

[283]  J. Arbeit,et al.  c-Jun is essential for organization of the epidermal leading edge. , 2003, Developmental cell.

[284]  M. Tsang,et al.  Human epidermal growth factor enhances healing of diabetic foot ulcers. , 2003, Diabetes care.

[285]  M. Giacca,et al.  Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse , 2003, Diabetologia.

[286]  N. Gibran,et al.  Human Dermal Microvascular Endothelial Cells Produce Nerve Growth Factor: Implications for Wound Repair , 2003, Shock.

[287]  K. Yoshikawa,et al.  Neutralization of hepatocyte growth factor leads to retarded cutaneous wound healing associated with decreased neovascularization and granulation tissue formation. , 2003, The Journal of investigative dermatology.

[288]  A. Schor,et al.  Growth factors in the treatment of diabetic foot ulcers , 2003, The British journal of surgery.

[289]  Jie Li,et al.  Angiogenesis in wound repair: Angiogenic growth factors and the extracellular matrix , 2003, Microscopy research and technique.

[290]  Y. Nimura,et al.  Effect of chitosan film containing basic fibroblast growth factor on wound healing in genetically diabetic mice. , 2003, Journal of biomedical materials research. Part A.

[291]  Geoffrey C Gurtner,et al.  Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. , 2003, The American journal of pathology.

[292]  G. Gurtner,et al.  Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures , 2002, Circulation.

[293]  DOUGLAS G. Smith,et al.  Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. , 2002, The Journal of surgical research.

[294]  Kunio Matsumoto,et al.  Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the sendai virus (hemagglutinating virus of Japan). , 2002, The American journal of pathology.

[295]  Y. Barde,et al.  The neurotrophin receptor p75NTR: novel functions and implications for diseases of the nervous system , 2002, Nature Neuroscience.

[296]  Linshu Liu,et al.  Hyaluronate-heparin conjugate gels for the delivery of basic fibroblast growth factor (FGF-2). , 2002, Journal of biomedical materials research.

[297]  L. Baddour Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection , 2002, Current infectious disease reports.

[298]  G Zambruno,et al.  Adenovirus-mediated VEGF165 gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice , 2002, Gene Therapy.

[299]  P. D. Felipe Polycistronic Viral Vectors , 2002 .

[300]  A. Boulton,et al.  Transforming growth factor‐beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[301]  P. Schirmacher,et al.  Resistance of keratinocytes to TGFbeta-mediated growth restriction and apoptosis induction accelerates re-epithelialization in skin wounds. , 2002, Journal of cell science.

[302]  Peter G Smith,et al.  Impaired cutaneous wound healing after sensory denervation in developing rats: effects on cell proliferation and apoptosis , 2002, Cell and Tissue Research.

[303]  P. de Felipe Polycistronic viral vectors. , 2002, Current gene therapy.

[304]  Yves-Alain Barde,et al.  The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. , 2002, Nature neuroscience.

[305]  L. Lau,et al.  The Angiogenic Factor Cyr61 Activates a Genetic Program for Wound Healing in Human Skin Fibroblasts* , 2001, The Journal of Biological Chemistry.

[306]  M. Takigawa,et al.  CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). , 2001, European journal of biochemistry.

[307]  M. Mori,et al.  Overexpression of hepatocyte growth factor/scatter factor promotes vascularization and granulation tissue formation in vivo , 2001, FEBS letters.

[308]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[309]  J. Varga,et al.  Transforming Growth Factor-β Repression of Matrix Metalloproteinase-1 in Dermal Fibroblasts Involves Smad3* , 2001, The Journal of Biological Chemistry.

[310]  Injoong Kim,et al.  Wound epithelialization deficits in the transforming growth factor‐α knockout mouse , 2001 .

[311]  M. Skobe,et al.  Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. , 2001, The American journal of pathology.

[312]  John Harmon,et al.  Success and limitations of a naked plasmid transfection protocol for keratinocyte growth factor‐1 to enhance cutaneous wound healing , 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[313]  W. Timens,et al.  Keratinocyte‐derived growth factors play a role in the formation of hypertrophic scars , 2001, The Journal of pathology.

[314]  Takayuki Asahara,et al.  The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors , 2001, Nature Medicine.

[315]  J. Pfeilschifter,et al.  Expressional Regulation of Angiopoietin-1 and -2 and the Tie-1 and -2 Receptor Tyrosine Kinases during Cutaneous Wound Healing: A Comparative Study of Normal and Impaired Repair , 2001, Laboratory Investigation.

[316]  M. Stacey,et al.  Mitogenic activity and cytokine levels in non‐healing and healing chronic leg ulcers , 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[317]  K. Alitalo,et al.  VEGF‐C and VEGF‐D expression in neuroendocrine cells and their receptor, VEGFR‐3, in fenestrated blood vessels in human tissues , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[318]  C. Powers,et al.  Fibroblast growth factors, their receptors and signaling. , 2000, Endocrine-related cancer.

[319]  J. Pfeilschifter,et al.  Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. , 2000, The Journal of investigative dermatology.

[320]  G. Sibbald,et al.  Recombinant human platelet‐derived growth factor‐BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open‐label clinical evaluation of efficacy , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[321]  A. Boulton,et al.  Lack of insulin‐like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers , 2000, The Journal of pathology.

[322]  W. Hasan,et al.  Coordinate expression of NGF and α-smooth muscle actin mRNA and protein in cutaneous wound tissue of developing and adult rats , 2000, Cell and Tissue Research.

[323]  Whei-Min Lin,et al.  Pathology of Nerve Terminal Degeneration in the Skin , 2000, Journal of neuropathology and experimental neurology.

[324]  Jerry S. Vandeberg,et al.  Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response. , 2000, Annals of surgery.

[325]  B H Perry,et al.  Efficacy and safety of becaplermin (recombinant human platelet‐derived growth factor‐BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[326]  Anita B. Roberts,et al.  Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response , 1999, Nature Cell Biology.

[327]  S. Akira,et al.  Keratinocyte‐specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis , 1999, The EMBO journal.

[328]  G. Onder,et al.  Effect of topical application of nerve-growth factor on pressure ulcers , 1999, The Lancet.

[329]  Floyd,et al.  Cellular changes in denervated tissue during wound healing in a rat model , 1999, British Journal of Dermatology.

[330]  F. Sundler,et al.  Neuropeptide‐containing C‐fibres and wound healing in rat skin. Neither capsaicin nor peripheral neurotomy affect the rate of healing , 1999, The British journal of dermatology.

[331]  C. Heldin,et al.  Mechanism of action and in vivo role of platelet-derived growth factor. , 1999, Physiological reviews.

[332]  L. Hudson,et al.  Contributions of the epidermal growth factor receptor to keratinocyte motility , 1998, Microscopy research and technique.

[333]  L. Hudson,et al.  Epidermal growth factor (EGF)‐ and scatter factor/hepatocyte growth factor (SF/HGF)‐mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)‐9 , 1998, Journal of cellular physiology.

[334]  M. Clauss,et al.  Functions of the VEGF receptor-1 (FLT-1) in the vasculature. , 1998, Trends in cardiovascular medicine.

[335]  M. Lehnhardt,et al.  Determination of Endogenous Growth Factors in Human Wound Fluid: Temporal Presence and Profiles of Secretion , 1998, Plastic and reconstructive surgery.

[336]  R. Gamelli,et al.  Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. , 1998, The American journal of pathology.

[337]  J. Smiell,et al.  Efficacy and Safely of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients With Chronic Neuropathic Diabetic Ulcers: A phase III randomized placebo-controlled double-blind study , 1998, Diabetes Care.

[338]  B. S. Srivastava,et al.  Differential expression of proteins during healing of cutaneous wounds in experimental normal and chronic models. , 1998, Biochemical and biophysical research communications.

[339]  E. Ingham,et al.  Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. , 1998, British Journal of Cancer.

[340]  H. Matsuda,et al.  Role of Nerve Growth Factor in Cutaneous Wound Healing: Accelerating Effects in Normal and Healing-impaired Diabetic Mice , 1998, Journal of Experimental Medicine.

[341]  I. Tack,et al.  Activation of Flk-1/KDR mediates angiogenesis but not hypotension. , 1997, Cardiovascular research.

[342]  T Nakamura,et al.  Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. , 1997, Biochemical and biophysical research communications.

[343]  M. Edmonds,et al.  Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection , 1997, The Lancet.

[344]  D. Greenhalgh,et al.  Differential expression and localization of insulin-like growth factors I and II in cutaneous wounds of diabetic and nondiabetic mice. , 1997, The American journal of pathology.

[345]  E. Eriksson,et al.  Growth Factors in the Repair of Partial Thickness Porcine Skin Wounds , 1997, Plastic and reconstructive surgery.

[346]  S. Werner,et al.  Reduced expression of PDGF and PDGF receptors during impaired wound healing. , 1997, The Journal of investigative dermatology.

[347]  K. Plate,et al.  Angiogenesis in Embryos and Ischemic Diseases , 1997, Thrombosis and Haemostasis.

[348]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[349]  D. Rifkin,et al.  Biological roles of fibroblast growth factor-2. , 1997, Endocrine reviews.

[350]  M. Robson The role of growth factors in the healing of chronic wounds , 1997, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[351]  K. Atabay,et al.  Delayed Effect of Denervation on Wound Contraction in Rat Skin , 1996, Plastic and reconstructive surgery.

[352]  G. Schultz,et al.  Interactions of cytokines, growth factors, and proteases in acute and chronic wounds , 1996, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[353]  C. MacArthur,et al.  Receptor Specificity of the Fibroblast Growth Factor Family* , 1996, The Journal of Biological Chemistry.

[354]  P. Kopelman,et al.  The role of endogenous nerve growth factor in human diabetic neuropathy , 1996, Nature Medicine.

[355]  L. Hudson,et al.  Enhanced Modulation of Keratinocyte Motility by Transforming Growth Factor-α (TGF-α) Relative to Epidermal Growth Factor (EGF) , 1996 .

[356]  J. Watters,et al.  The influence of age on the severity of peritonitis. , 1996, Canadian journal of surgery. Journal canadien de chirurgie.

[357]  M. Bitar,et al.  Transforming growth factor-beta and insulin-like growth factor-I in relation to diabetes-induced impairment of wound healing. , 1996, The Journal of surgical research.

[358]  Whei-Min Lin,et al.  Epidermal denervation and its effects on keratinocytes and Langerhans cells , 1996, Journal of neurocytology.

[359]  L. Hudson,et al.  Enhanced modulation of keratinocyte motility by transforming growth factor-alpha (TGF-alpha) relative to epidermal growth factor (EGF). , 1996, The Journal of investigative dermatology.

[360]  Atsushi Namiki,et al.  Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[361]  A. Roberts,et al.  Transforming growth factor-beta: activity and efficacy in animal models of wound healing. , 1995, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[362]  J. Erusalimsky,et al.  Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. , 1995, Circulation.

[363]  M. Longaker,et al.  Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes. , 1995, The Journal of Biological Chemistry.

[364]  P. Hofschneider,et al.  The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. , 1994, Science.

[365]  M. Shibuya,et al.  Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. , 1994, The Journal of biological chemistry.

[366]  H. Asada,et al.  Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. , 1994, The Journal of biological chemistry.

[367]  Atsushi Namiki,et al.  Indirect Angiogenic Cytokines Upregulate VEGF and bFGF Gene Expression in Vascular Smooth Muscle Cells, Whereas Hypoxia Upregulates VEGF Expression Only , 1994 .

[368]  M. P. Welch,et al.  TGF-beta 1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. , 1994, The Journal of investigative dermatology.

[369]  Rebeccah L. Brown,et al.  PDGF and TGF-α Act Synergistically to Improve Wound Healing in the Genetically Diabetic Mouse , 1994 .

[370]  R. Young,et al.  The Prevalence of Foot Ulceration and its Correlates in Type 2 Diabetic Patients: a Population‐based Study , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[371]  D. Greenhalgh,et al.  PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse. , 1994, The Journal of surgical research.

[372]  E. Brogi,et al.  Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. , 1994, Circulation.

[373]  P. Bork The modular architecture of a new family of growth regulators related to connective tissue growth factor , 1993, FEBS letters.

[374]  M. Blumenberg,et al.  Epidermal growth factor and transforming growth factor alpha specifically induce the activation- and hyperproliferation-associated keratins 6 and 16. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[375]  A. Desmoulière,et al.  Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts , 1993, The Journal of cell biology.

[376]  R. Derynck,et al.  Autonomous growth of human keratinocytes requires epidermal growth factor receptor occupancy. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[377]  M. Klagsbrun,et al.  Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[378]  J. Massagué,et al.  Membrane-anchored growth factors. , 1993, Annual review of biochemistry.

[379]  D. Dimitrov,et al.  Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. , 1992, Biochemical and biophysical research communications.

[380]  G F Pierce,et al.  Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. , 1992, The American journal of pathology.

[381]  J. D. Benson,et al.  Insulin-like growth factors I and II expression in the healing wound. , 1992, The Journal of surgical research.

[382]  H Ueno,et al.  The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. , 1992, Science.

[383]  Gary R. Grotendorst,et al.  Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10 , 1991, The Journal of cell biology.

[384]  Gregory S. Schultz,et al.  EGF and TGF‐α in wound healing and repair , 1991 .

[385]  T. Fahey,et al.  Diabetes impairs the late inflammatory response to wound healing. , 1991, The Journal of surgical research.

[386]  G. Schultz,et al.  EGF and TGF-alpha in wound healing and repair. , 1991, Journal of cellular biochemistry.

[387]  D. Greenhalgh,et al.  PDGF and FGF stimulate wound healing in the genetically diabetic mouse. , 1990, The American journal of pathology.

[388]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.

[389]  K. Kristensson,et al.  Nerve fibre studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuropeptides in diabetes mellitus , 1989, Journal of Neurological Sciences.

[390]  L. Nanney,et al.  Enhancement of wound healing by topical treatment with epidermal growth factor. , 1989, The New England journal of medicine.

[391]  M. White,et al.  Acceleration of tensile strength of incisions treated with EGF and TGF-beta. , 1988, Annals of surgery.

[392]  M J Banda,et al.  Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. , 1988, Science.

[393]  H. Moses,et al.  Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta , 1987, Journal of Experimental Medicine.

[394]  R. Derynck,et al.  Production and auto-induction of transforming growth factor-alpha in human keratinocytes. , 1987, Nature.

[395]  Harold L. Moses,et al.  Production and auto-induction of transforming growth factor-α in human keratinocytes , 1987, Nature.

[396]  R. Baxter,et al.  Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. , 1986, The Journal of clinical investigation.

[397]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[398]  H. Polk,et al.  Enhancement of epidermal regeneration by biosynthetic epidermal growth factor , 1986, The Journal of experimental medicine.

[399]  R. Helme,et al.  The effect of nerve lesions on the inflammatory response to injury , 1985, Journal of neuroscience research.

[400]  F A Matsen,et al.  Transcutaneous oxygen tension measurements on limbs of diabetic and nondiabetic patients with peripheral vascular disease. , 1984, Surgery.

[401]  M. Sporn,et al.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. , 1983, The Journal of biological chemistry.

[402]  Maria Fitzgerald,et al.  Capsaicin and sensory neurones — a review , 1983, Pain.

[403]  F. Lembeck,et al.  DECREASE OF SUBSTANCE P IN PRIMARY AFFERENT NEURONES AND IMPAIRMENT OF NEUROGENIC PLASMA EXTRAVASATION BY CAPSAICIN , 1980, British journal of pharmacology.

[404]  H. Green,et al.  Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes , 1977, Nature.

[405]  J. Bagdade,et al.  Impaired Leukocyte Function in Patients with Poorly Controlled Diabetes , 1974, Diabetes.

[406]  J. Szolcsányi,et al.  Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. , 1967, British journal of pharmacology and chemotherapy.

[407]  D. E. Rogers,et al.  THE PHAGOCYTIC ACTIVITY OF POLYMORPHONUCLEAR LEUKOCYTES OBTAINED FROM PATIENTS WITH DIABETES MELLITUS. , 1964, The Journal of laboratory and clinical medicine.